Abstract:During natural evolution, the spindles often scale with cell sizes to orchestrate accurate chromosome segregation. Whether in cancer evolution, when the constraints on genome integrity are relaxed, cancer cells may evolve the spindle to confer other advantages has not been investigated. Using invasion as a selective pressure in vitro, we found that a highly metastatic cancer clone displays a lengthened metaphase spindle, with faster spindle elongation that correlates with transiently elevated speed of cell mig… Show more
“…Inspired by such limitations, we used a repeated sphere-forming assay as a strategy to select a malignant cell line that was phenotypically stable. This is conceptually parallel to our previous establishment of a series of metastatic cell lines using repeated invasion assays 15,16 . Such model cell lines have been used to identify genes or cellular phenotypes that are associated with metastasis 16,17 .…”
Section: Introductionmentioning
confidence: 67%
“…This is conceptually parallel to our previous establishment of a series of metastatic cell lines using repeated invasion assays 15,16 . Such model cell lines have been used to identify genes or cellular phenotypes that are associated with metastasis 16,17 . In this study, with a repeated sphere-forming assay, we aimed to select a malignant clone from a HCT116 CRC cell line.…”
Colorectal cancer (CRC) is a leading cause of death from cancer worldwide. Thus, there is an emerging need for new experimental models that allow identification and validation of biomarkers for CRC-specific progression. In this study, we propose a repeated sphere-forming assay as a strategy to select a malignant subpopulation from a CRC line, HCT116. We validated our assay by confirming that three canonical stemness markers, Nanog, Oct4, and Lgr5, were up-regulated in the sphere state at every generation of the selection assay. The resulting line, after eight rounds of selection, exhibited an increased sphere-forming capacity in vitro and tumorgenicity in vivo. Furthermore, dipeptidase 1 (DPEP1) was identified as the major differentially expressed gene in the selected clone, and depletion of DPEP1 suppressed the elevated sphere-forming capacity in vitro and tumorgenicity in vivo. Overall, we have established an experimental strategy for the isolation of a malignant subpopulation from a CRC cell line. Results from our model also suggested that DPEP1 can serve as a promising prognostic biomarker for CRC.
“…Inspired by such limitations, we used a repeated sphere-forming assay as a strategy to select a malignant cell line that was phenotypically stable. This is conceptually parallel to our previous establishment of a series of metastatic cell lines using repeated invasion assays 15,16 . Such model cell lines have been used to identify genes or cellular phenotypes that are associated with metastasis 16,17 .…”
Section: Introductionmentioning
confidence: 67%
“…This is conceptually parallel to our previous establishment of a series of metastatic cell lines using repeated invasion assays 15,16 . Such model cell lines have been used to identify genes or cellular phenotypes that are associated with metastasis 16,17 . In this study, with a repeated sphere-forming assay, we aimed to select a malignant clone from a HCT116 CRC cell line.…”
Colorectal cancer (CRC) is a leading cause of death from cancer worldwide. Thus, there is an emerging need for new experimental models that allow identification and validation of biomarkers for CRC-specific progression. In this study, we propose a repeated sphere-forming assay as a strategy to select a malignant subpopulation from a CRC line, HCT116. We validated our assay by confirming that three canonical stemness markers, Nanog, Oct4, and Lgr5, were up-regulated in the sphere state at every generation of the selection assay. The resulting line, after eight rounds of selection, exhibited an increased sphere-forming capacity in vitro and tumorgenicity in vivo. Furthermore, dipeptidase 1 (DPEP1) was identified as the major differentially expressed gene in the selected clone, and depletion of DPEP1 suppressed the elevated sphere-forming capacity in vitro and tumorgenicity in vivo. Overall, we have established an experimental strategy for the isolation of a malignant subpopulation from a CRC cell line. Results from our model also suggested that DPEP1 can serve as a promising prognostic biomarker for CRC.
“…These defects contribute to tumor heterogeneity and cancer progression [81]. Additional chromosomes pose a challenge for mitotic cells, as they require larger spindles to ensure that all chromosomes are associated with MTs prior to anaphase onset [82,83,84,85]. We propose that dynamic changes in bipolar spindle length, driven by cortical dynein activity, contributes to the spindle length requirements for chromosome capture and alignment, with particular relevance to cancer contexts where chromosome number is increased.…”
Proper formation and maintenance of the mitotic spindle is required for faithful cell division. While much work has been done to understand the roles of the key force components of the mitotic spindle, identifying the implications of force perturbations in the spindle remains a challenge. We developed a computational framework of the minimal force requirements for mitotic progression and used experimental approaches to further define and validate the model. Through simulations, we show that rather than achieving and maintaining a constant bipolar spindle length, oscillations in pole to pole distance occur that coincide with microtubule binding and force generation by cortical dynein. In the context of high kinesin-14 (HSET) activity, we reveal the requirement of high cortical dynein activity for bipolar spindle formation.
“…In order to overcome the aforementioned limitations, the present study used a repeated sphere-forming assay as a strategy to select a malignant subpopulation that was phenotypically stable. Conceptually, this strategy is similar to the previous establishment of a series of metastatic cell lines using repeated invasion assays (16,17). Such model cell lines have been used to identify genes or cellular phenotypes that are associated with metastasis (17,18).…”
Section: Selection Of a Malignant Subpopulation From A Colorectal Canmentioning
Colorectal cancer (CRC) is a leading cause of cancer-associated mortality worldwide; therefore, there is an emerging need for novel experimental models that allow for the identification and validation of biomarkers for CRC-specific progression. In the present study, a repeated sphere-forming assay was used as a strategy to select a malignant subpopulation from a CRC cell line, namely HCT116. The assay was validated by confirming that canonical stemness markers were upregulated in the sphere state at every generation of the selection assay. The resulting subpopulation, after eight rounds of selection, exhibited increased sphere-forming capacity in vitro and increased tumorigenicity in vivo. Furthermore, dipeptidase 1 (DPEP1) was identified as the major differentially expressed gene in the selected clone, and its depletion suppressed the elevated sphere-forming capacity in vitro and tumorigenicity in vivo. Overall, the present study established an experimental strategy to isolate a malignant subpopulation from a CRC cell line. Additionally, results from the present model revealed that DPEP1 may serve as a promising prognostic biomarker for CRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.